Amgen Inc.

    Amgen Inc.

    HHKEX:4332
    1,850.00
    HKD
    0.00
    (0.00%)
    14.57P/E
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    24.8
    26.43
    28.58
    30.74
    31.26
    35.93
    38.61
    43.39
    45.58
    48.93
    52.69
    62.24
    68.31
    70.61
    Basic EPS, GAAP
    6.75
    6.8
    9.15
    10.32
    2.71
    12.7
    12.96
    12.4
    10.34
    12.18
    12.56
    7.62
    14.33
    16.21
    Free Cash Flow per Basic Share
    7.43
    10.47
    11.98
    12.72
    14.38
    15.97
    14.1
    16.88
    14.7
    16.33
    13.76
    19.36
    15.06
    18.86
    Dividend per Share
    1.88
    2.44
    3.16
    4.01
    4.6
    5.31
    5.8
    6.41
    7.04
    7.8
    8.52
    9
    9.52
    9.8
    Book Value per Share
    29.28
    33.9
    37.25
    40.48
    34.95
    19.85
    16.36
    16.27
    12
    6.86
    11.64
    10.94
    16.07
    21.62
    Tangible Book Value per Share
    -8.13
    -2.24
    2.19
    6.57
    2.59
    -15.31
    -41.33
    -37.81
    -41.86
    -52.34
    -84.12
    -75.34
    -59.94
    -50.81
    Basic Weighted Avg Shares
    753
    759
    758
    748
    731
    661
    605
    586
    570
    538
    535
    537
    538
    540
    Sales/Revenue/Turnover
    18,676
    20,063
    21,662
    22,991
    22,849
    23,747
    23,362
    25,424
    25,979
    26,323
    28,190
    33,424
    36,751
    38,095
    Operating Margin (%)
    31.41
    30.86
    39.1
    42.6
    43.65
    43.22
    41.41
    35.95
    29.4
    36.34
    28.01
    21.71
    24.71
    29.99
    Depreciation Expense
    1,286
    2,092
    2,108
    2,105
    1,955
    1,946
    2,206
    3,601
    3,398
    3,417
    4,071
    5,592
    5,167
    4,667
    Net Income, GAAP
    5,081
    5,158
    6,939
    7,722
    1,979
    8,394
    7,842
    7,264
    5,893
    6,552
    6,717
    4,090
    7,711
    8,743
    Effective Tax Rate (%)
    3.49
    7.65
    13.02
    15.73
    79.38
    12.06
    14.18
    10.68
    12.06
    10.81
    14.49
    11.26
    14.09
    15.01
    Profit Margin (%)
    27.21
    25.71
    32.03
    33.59
    8.66
    35.35
    33.57
    28.57
    22.68
    24.89
    23.83
    12.24
    20.98
    22.95
    Working Capital
    19,420
    27,705
    29,851
    34,806
    40,456
    24,130
    5,605
    9,491
    7,201
    6,499
    11,940
    5,931
    3,568
    9,459
    LT Debt
    29,623
    30,215
    29,182
    30,193
    34,190
    29,510
    26,950
    32,895
    33,222
    37,354
    63,170
    56,549
    50,005
    51,859
    Total Equity
    22,096
    25,778
    28,083
    29,875
    25,241
    12,500
    9,673
    9,409
    6,700
    3,661
    6,232
    5,877
    8,658
    11,688
    Return on Invested Capital (%)
    11.35
    10.33
    12.7
    13.31
    3.29
    16.87
    19.18
    19.58
    16.01
    20.19
    11.61
    9.13
    11.8
    14.64
    Return on Capital (%)
    12.16
    11.1
    13.61
    14.17
    3.6
    17.98
    20.81
    20.47
    16.86
    18.9
    16.18
    10.07
    15.6
    16.6
    Return on Common Equity (%)
    24.69
    21.55
    25.77
    26.65
    7.18
    44.48
    70.73
    76.13
    73.16
    126.47
    135.79
    67.55
    106.1
    91.47

    Capital Structure

    USD

    •

    in mil. unless spec.
    Dec'25
    Mar'26
    Jun'26
    ST Debt
    4,599
    5,437
    5,445
    LT Borrowings
    50,005
    51,886
    51,859
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    539
    540
    541
    Market Capitalization
    128,046
    127,332
    127,624

    Working Capital

    USD

    •

    in mil. unless spec.
    Dec'25
    Mar'26
    Jun'26
    Total Current Assets
    29,057
    31,475
    34,961
    Cash, Cash Equivalents & STI
    9,129
    12,038
    13,989
    Accounts Receivable, Net
    9,570
    9,138
    10,227
    Inventories
    6,225
    6,186
    6,220
    Total Current Liabilities
    25,489
    24,955
    25,502
    Payables & Accruals
    19,453
    19,518
    20,057
    ST Debt
    4,599
    5,437
    5,445
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    -4.73%
    7.54%
    47.32%
    Free Cash Flow
    0.49%
    -1.5%
    -22.07%
    Net Income, GAAP
    29.14%
    8.85%
    88.53%
    Sales/Revenue/Turnover
    5.58%
    7.82%
    9.95%
    Total Cash Common Dividend
    8.08%
    6.42%
    6.04%

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    7,447
    8,388
    8,503
    9,086
    33,424
    2025
    8,149
    9,179
    9,557
    9,866
    36,751
    2026
    8,618
    10,054
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    -0.21
    1.39
    5.27
    1.17
    7.62
    2025
    3.22
    2.66
    - -
    2.47
    14.33
    2026
    3.37
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    2.25
    2.25
    2.25
    2.24
    9
    2025
    2.38
    2.38
    - -
    2.38
    9.52
    2026
    2.51
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business